868
C. Kuang et al. · Novel Functionalized (E)-β-Arylvinyl Bromides
for C12H1379BrO2, [M]+). – C12H13BrO2 (269.13): calcd. Phenyl (E)-4-(2-bromovinyl)benzoate (4f)
C 53.55, H 4.87, Br 29.69; found C 53.64, H 4.90, Br 29.74.
Prepared from compound 1 and ◦phenol (3f), 248 mg
(82 %). White solid, m. p. 112 – 113 C (hexane/EtOAc). –
IR (KBr): ν = 1729 (C=O), 1261, 1072, 940, 741 cm−1. –
1H NMR (300 MHz, CDCl3): δ = 6.99 (d, J = 14.1 Hz,
1H, Br-CH=CH-), 7.17 – 7.23 (m, 3H; 2H of Ph, 1H, Ar-
CH=CH-), 7.30 (d, J = 7.8 Hz, 1H of Ph), 7.42 – 7.47 (m,
4H, 4H of Ph), 8.17 (d, J = 8.1 Hz, 2H of Ph). – 13C NMR
(75 MHz, CDCl3): δ = 109.85, 121.60 (2 × C), 125.88
(3 × C), 126.08 (2 × C), 129.45 (2 × C), 130.67 (2 × C),
136.23, 140.66, 165.90. – MS (EI): m/z (%) = 304 (48)
[M+2]+, 302 (47) [M]+, 228 (36), 226 (35), 211 (99), 209
(100), 102 (89). – HRMS: m/z = 301.9945 (calcd. 301.9942
for C15H1179BrO2, [M]+). – C15H11BrO2 (303.15): calcd.
C 59.43, H 3.66, Br 26.36; found C 59.48, H 3.69, Br 26.40.
Octyl (E)-4-(2-bromovinyl)benzoate (4c)
Prepared from compound 1 and octan-1-ol (3c), 305 mg
(90 %). Colorless oil. – IR (neat): ν = 1714 (C=O), 1271,
1
1103, 935, 741 cm−1. – H NMR (300 MHz, CDCl3): δ =
0.88 (t, J = 7.4 Hz, 3H, CH3-CH2), 1.28 – 1.95 (m, 12H,
-CH2-), 4.31 (t, J = 6.6 Hz, 2H, -OCH2-CH2-), 6.92 (d, J =
14.3 Hz, 1H, Br-CH=CH-), 7.14 (d, J = 14.3 Hz, 1H, Ar-
CH=CH-), 7.36 (d, J = 8.2 Hz, 2H of Ph), 8.00 (d, J =
8.2 Hz, 2H of Ph). – 13C NMR (75 MHz, CDCl3): δ = 14.03,
22.58, 25.39, 29.13, 29.18, 31.72, 34.85, 65.18, 109.23,
125.85, 130.01, 130.08, 135.32, 139.89, 168.11. – MS (EI):
m/z (%) = 340 (45) [M+2]+, 338 (46) [M]+, 228 (36), 226
(35), 211 (99), 209 (100), 102 (89). – HRMS: m/z = 338.0880
(calcd. 338.0882 for C17H2379BrO2, [M]+). – C17H23BrO2
(339.27): calcd. C 60.18, H 6.83, Br 23.55; found C 60.24,
H 6.79, Br 23.58.
5-Isopropyl-2-methylphenyl (E)-4-(2-bromovinyl) benzoate
(4g)
Prepared from compound 1 and 5-isopropyl-2-methyl-
phenol (3g), 331 mg (92 %). Colorless oil. – IR (neat):
ν = 1729 (C=O), 1261, 1082, 935, 746 cm−1. – 1H NMR
(300 MHz, CDCl3): δ = 1.16 (d, J = 12.9 Hz, 6H, CH3-CH-),
2.27 (s, 3H, Ar-CH3), 2.91 – 3.01 (q, J = 6.2 Hz, 1H, -CH-
CH3), 6.86 – 7.01 (m, 3H, Br-CH=CH-, 2H of Ph), 7.09 –
7.19 (m, 2H, Ar-CH=CH-, 1H of Ph), 7.37 (d, J = 8.2 Hz, 2H
of Ph), 8.10 (d, J = 8.2 Hz, 2H of Ph). – 13C NMR (75 MHz,
CDCl3): δ = 20.82, 25.42, 27.25, 109.85, 122.78, 126.16,
126.46, 127.20, 129.06, 130.65, 136.24, 136.63, 137.09,
140.64, 148.04, 164.85. – MS (EI): m/z (%) = 360 (48)
[M+2]+, 358 (47) [M]+, 228 (36), 226 (35), 211 (99), 209
(100), 102 (89). – HRMS: m/z = 358.0569 (calcd. 358.0569
for C19H1979BrO2, [M]+). – C19H19BrO2 (359.26): calcd.
C 63.52, H 5.33, Br 22.24; found C 63.48, H 5.38, Br 22.38.
Cyclohexyl(E)-4-(2-bromovinyl)benzoate (4d)
Prepared from compound 1 and cyclohexanol (3d),
284 mg (92 %). White solid, m. p. 61 – 62 ◦C (hex-
ane/EtOAc). – IR (KBr): ν = 1714 (C=O), 1270, 1103, 935,
1
751 cm−1. – H NMR (300 MHz, CDCl3): δ = 1.10 – 1.86
(m, 10H, -CH2-), 4.92 – 4.98 (m, 1H, -OCH-), 6.84 (d, J =
14.2 Hz, 1H, Br-CH=CH-), 7.07 (d, J = 14.2 Hz, 1H, Ar-
CH=CH-), 7.28 (d, J = 8.2 Hz, 2H of Ph), 7.93 (d, J =
8.2 Hz, 2H of Ph). – 13C NMR (75 MHz, CDCl3): δ =
23.61, 24.64, 31.57, 73.14, 109.13, 125.82, 130.01, 130.49,
136.37, 139.78, 165.45. – MS (EI): m/z (%) = 310 (49)
[M+2]+, 308 (48) [M]+, 228 (39), 226 (38), 211 (99), 209
(100), 102 (90). – HRMS: m/z = 308.0410 (calcd. 308.0412
for C15H1779BrO2, [M]+). – C15H17BrO2 (309.20): calcd.
C 58.27, H 5.54, Br 25.84; found C 58.30, H 5.62, Br 25.80.
4-(Formylphenyl) (E)-4-(2-bromovinyl)benzoate (4h)
Benzyl (E)-4-(2-bromovinyl)benzoate (4e)
Prepared from compound 1 and 4-hydroxybenzaldehyde
◦
Prepared from compound 1 and phenylmethanol (3e), (3h), 308 mg (93 %). White solid, m. p. 163 – 164 C (hex-
285 mg (90 %). White solid, m. p. 50 – 52 ◦C (hex- ane/EtOAc). – IR (KBr): ν = 1741 (C=O), 1734 (C=O),
ane/EtOAc). – IR (KBr): ν = 1714 (C=O), 1261, 1082, 1271, 1072, 940, 741 cm−1. – 1H NMR (300 MHz, CDCl3):
940, 751 cm−1. – 1H NMR (300 MHz, CDCl3): δ = 5.28 δ = 7.01 (d, J = 14.2 Hz, 1H, Br-CH=CH-), 7.20 (d, J =
(s, 2H, -CH2-Ph), 6.83 (d, J = 14.1 Hz, 1H, Br-CH=CH-), 14.2 Hz, 1H, Ar-CH=CH-), 7.40 – 7.47 (m, 4H of Ph), 7.99
7.05 (d, J = 14.1 Hz, 1H, Ar-CH=CH-), 7.28 – 7.38 (m, (d, J = 8.4 Hz, 2H of Ph), 8.17 (d, J = 8.1Hz, 2H of
7H, 2H of Ph, 5H of Ph), 7.95 (d, J = 8.3 Hz, 2H of Ph), 10.04 (s, 1H, -CHO). – 13C NMR (75 MHz, CDCl3):
Ph). – 13C NMR (75 MHz, CDCl3): δ = 66.75, 109.45, δ = 110.27, 122.43, 126.20, 128.27, 130.78, 131.22, 134.06,
125.93, 128.16, 128.26, 128.57, 129.58, 130.21, 135.90, 136.10, 141.10, 155.54, 164.01, 190.82. – MS (EI): m/z
136.29, 140.14, 165.90. – MS (EI): m/z ( %) = 318 (48) (%) = 332 (90) [M+2]+, 330 (92) [M]+, 228 (36), 226 (35),
[M+2]+, 316 (47) [M]+, 228 (36), 226 (35), 211 (99), 209 211 (99), 209 (100), 102 (89). – HRMS: m/z = 329.9888
(100), 102 (89). – HRMS: m/z = 316.0099 (calcd. 316.0098 (calcd. for C16H1179BrO3, [M]+). – C16H11BrO3 (331.16):
for C16H1379BrO2, [M]+). – C16H13BrO2 (317.18): calcd. calcd. C 58.03, H 3.35, Br 24.13; found C 58.10, H 3.30,
C 60.59, H 4.13, Br 25.19; found C 60.62, H 4.20, Br 25.22. Br 24.19.
Unauthenticated
Download Date | 11/17/19 11:52 PM